Persephoni BioPartners will be at PACT! Reach out to connect with any member of our team!
Persephoni BioPartners
Business Consulting and Services
Strategic Development Services for Early-Stage Biotechnology Companies
About us
Our Vision At Persephoni Biosciences, our vision is to be a global leader in biotechnology by supporting companies from early-stage business development through commercialization. We help scientists navigate the complexities of the business landscape so they can drive innovation. Our Expertise With decades of combined experience in biotechnology and startup development, our team has the resources to provide solutions for all aspects of company growth including R&D, Capital Raise, IP Strategy, and Business Development. Our unique proposition lies within our venture studio model, providing direct support services and guidance throughout all stages of business development and commercialization. We Partner Through our venture, research, and pharma collaborations, we to de-risk and accelerate the advancement of breakthrough through technologies, enabling partners to have line of sight and the needed pressure testing on ideas.
- Website
-
www.persephonibio.com
External link for Persephoni BioPartners
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Type
- Privately Held
- Founded
- 2024
- Specialties
- Research an Development, Company Formation, Fundraising, Therapeutics, and Advisory
Employees at Persephoni BioPartners
-
Brett Abrahams
Biotech Builder & Executive | Drug Developer | Board Member
-
George Buchlis
Principal, Scientific Lead at Persephoni BioPartners
-
William Heath
Chief Scientific Officer at Persephoni BioPartners | Experienced Biopharmaceutical R&D Leader | Champion for Diversity, Equity, Inclusion and…
-
Geraldine Ezeka, PhD
Biotech company strategist
Updates
-
🎉Announcements coming soon! 🎉 ☑️Portfolio selections 📈Capital Raised. #️⃣of Companies Served 🧬 Institutuonal Partnerships 💰Capital Partners And 2025 LAUNCHING our Fund!
CEO @ Persephoni BioPartners | Biotech Entrepreneurship | Investor | VC | Scientist | Chairman
🎉Operation prep for non stealth mode🎉 It has been so hard to restrain shouting from the rooftops… we have been putting in work, and it’s paying off! Persephoni BioPartners William Heath Donna Taraborelli
-
-
A big week for Persephoni! The saying goes… in the start up world, EVERYONE is a builder, fundraiser, janitor, locksmith, IT tech support… no task is above any one person, you do whatever it takes. What an exceptional group of talented leaders who believe in the vision of what we are building… added benefit, they can use power tools
-
-
Our home for the inventors we are enabling, the companies we are building, and the ideas we are helping to realize. We are creating a nurturing space where innovation in life sciences can flourish, supporting breakthroughs that will shape the future. By providing the resources and guidance needed, we turn unseen discoveries into reality and accelerate their path to patients. Here we grow!
-
-
We are incredibly proud and honored to have Dr. Donna Taraborelli join the executive leadership team at Persephoni BioPartners! Here We Grow!
🚀 People on the Move! 🚀 Donna Taraborelli has joined Persephoni BioPartners as their new Chief Operating Officer! 🎉 With over two decades of experience in clinical research, drug development, and executive leadership, Dr. Taraborelli is set to drive innovation and growth at Persephoni. From supporting Clearside Biomedical, Inc., Biomedical's IPO and FDA approval to advancing programs at Alcon and Merck, her track record speaks volumes. 🌟 Dr. Taraborelli's leadership will be instrumental in guiding early-stage biotech startups to success. 📢 Check out the full article to learn more about Dr. Taraborelli’s impressive journey and her role at Persephoni BioPartners! https://lnkd.in/eY4JV-_S #LifeSciences #Biotech #Leadership #Innovation #PeopleOnTheMove #PersephoniBioPartners #StartupSuccess #Healthcare
-
-
A very exciting achievement for our community partners at CIC (Cambridge Innovation Center)! Join us and celebrate this amazing achievement and hear from our CEO Hilary Schultz, as she discusses the critical need of advanced microscopy and AI technologies in pre clinical development. Panel Speakers CIC - Michelle Ottey, PhD , Ph.D. Vice President Labs and US Centers ZEISS - Vimal Gangadharan, Ph.D, Head of Growth Marketing & Apps Dev, Biotech/Pharma Ian Dardani, Ph.D, Co-founder, CEO, Biocartesian Hilary Schultz, MS, CEO, Persephoni “Accurate and accessible imaging is a clear differentiator for early preclinical development. The strength and accuracy of data equates to funding success, validating indications which translates to what can be taken to the clinic, and more than anything, enables the ability to discover the unknown.” - Hilary Schultz Event Details 🔗 https://lnkd.in/gQVVMeTN State of the Art Technology - learn about the resources 🔗 https://lnkd.in/gcNSN6FC
CIC (Cambridge Innovation Center) is excited to announce the official launch of the ZEISS Microscopy Solutions Center @ CIC! 🔬 Join us on Thursday, October 24th from 11 AM - 1 PM at CIC, 3675 Market Street, for an afternoon of innovation, connection, and celebration! ✨ The event will kick off with an exclusive panel discussion on the importance of early-stage life science companies’ access to cutting-edge microscopy technology—a crucial tool for advancing R&D milestones! Plus, we'll dive into how community partnerships are making this access possible. After the panel, stick around for a networking lunch, tours of our CIC labs, and the official ribbon-cutting ceremony! This is a fantastic opportunity to connect with experts, explore world-class lab spaces, and celebrate the launch of a new resource for life sciences here Philadelphia!
-
-
"Persephoni BioPartners Redefines the Blueprint for Biotech Startups" Business Insider At Persephoni BioPartners, we are proud to be highlighted in Business Insider, showcasing our dedication to accelerating life sciences innovation. This recognition underscores the impact our strategic consulting and leadership solutions bring to the biotech and pharmaceutical sectors. As we continue to help groundbreaking discoveries reach the patients who need them, we are grateful to Business Insider for recognizing our vision. This achievement would not have been possible without the incredible dedication and expertise of our team. Every milestone we reach is a testament to their hard work, innovative thinking, and unwavering commitment to transforming the landscape of life sciences. Together, we are pushing boundaries and driving real change. Thank you to our talented team for making this recognition possible—we couldn’t be more excited for what’s to come! CEO - Hilary Schultz CSO - William Heath COO - Donna Taraborelli Principal(s) - Eric Hacherl, George Buchlis, Geraldine Ezeka, PhD Sr. Associate(s) - Andrew Petryna, Emma Moulton Fellows - Ashraful Islam, Daniel Lin Operating Partner(s) - Brett Abrahams, Hans Christinger, Hsiao-Ling Hung, PhD, RAC, Frederick (Rick) Jones, Milad Riazifar, Ph.D., Ali Divan, Ph.D. Advisors - Shawn Fu, M.D., Tom Fisher ☁️ Operations Lead | Admin - Lisa Puccetti And thank you to the many strategic partners! BioBuzz, Chris Frew, CIC (Cambridge Innovation Center), Sarajane Blair, Heather A. Steinman, PhD, MBA, CYTO | PHL, Seed2Table, Kymanox
-
Please join us in welcoming Donna Taraborelli as our Chief Operating Officer!
Introducing Dr. Donna Taraborelli - Chief Operating Officer
Persephoni BioPartners on LinkedIn
-
We are growing! Announcements coming soon!
CEO @ Persephoni BioPartners | Biotech Entrepreneurship | Investor | VC | Scientist | Chairman
I love our team! Having team members from other regions come to our office is like feeling at home! A massive week for team Persephoni BioPartners Partnerships, portfolio selections, and interviews for our growing team 👏🏼 Donna Taraborelli William Heath Andrew Petryna Geraldine Ezeka, PhD Brett Abrahams
-